Merck's revenue per share for the
three
months ended in Dec. 2023 was €5.28.
Merck's revenue per share for the trailing twelve months (TTM) ended in Dec. 2023 was €21.92.
Warning Sign:
Merck & Co Inc revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue Per Share Growth Rate of Merck was 1.20% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 13.00% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 10.40% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was 5.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Merck's Revenue per Share or its related term are showing as below:
XPAR:MRK'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -16.5 Med: 8.4 Max: 22.8
Current: 13
During the past 13 years, Merck's highest 3-Year average Revenue Per Share Growth Rate was 22.80% per year. The lowest was -16.50% per year. And the median was 8.40% per year.
XPAR:MRK's 3-Year Revenue Growth Rate is ranked better than 70.96% of 923
companies
in the Drug Manufacturers industry
Industry Median: 6.4
vs XPAR:MRK: 13.00
Merck Revenue per Share Historical Data
The historical data trend for Merck's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Merck Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
Revenue per Share
13.65
13.43
16.98
22.02
21.64
Merck Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
Revenue per Share
5.12
5.30
5.47
5.87
5.28
Competitive Comparison
For the Drug Manufacturers - General subindustry, Merck's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Merck PS Ratio Distribution
For the Drug Manufacturers industry and Healthcare sector, Merck's PS Ratio distribution charts can be found below:
* The bar in red indicates where Merck's PS Ratio falls into.
Merck Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Merck's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €21.92
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Merck (XPAR:MRK) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Merck Revenue per Share Related Terms
Thank you for viewing the detailed overview of Merck's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XPAR:MRK has been successfully added to your 